-
A veteran multinational giant launches a 14 billion acquisition case, and domestic pharmaceutical companies have already laid out this heavyweight innovative drug
On Friday (December 22), Karuna Therapeutics, a US biopharmaceutical company listed on NASDAQ, rose 47% to $317.85 per share, breaking a historic high set in August last year, with a market value of ... -
High cost of electric vehicles persuades veteran automaker Ford CEO to reassess tram strategy
Ford CEO will reassess tram strategy due to high electric vehicle costs. Ford CEO Jim Farley stated on Tuesday (February 6) that the company is considering adjusting its electric vehicle strategy, in ...